marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Mirum Pharmaceuticals Financial Ratios 2011-2024 | MIRM
Annual Financial Ratios Mirum Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-6.7 | -5.9 | -5.8 | -4.6 | -3.7 | - | - | - | - | - | - | - | - |
P/S |
5.9 | 10.4 | 25.3 | - | - | - | - | - | - | - | - | - | - |
EPS |
-4 | -4.0 | -2.8 | -4.1 | -4.6 | - | - | - | - | - | - | - | - |
EV (Enterprise Value) |
1.21 B | 983 M | 627 M | 400 M | 198 M | 62.3 M | - | - | - | - | - | - | - |
EBITDA per Share |
-2.4 | -3.78 | -5.7 | -3.97 | -4.74 | - | - | - | - | - | - | - | - |
EV/EBITDA |
-3.5 | -3.2 | -3.3 | - | - | - | - | - | - | - | - | ||
PEG |
- | -0.43 | 0.81 | - | - | - | - | - | - | - | - | ||
P/B |
4.4 | 5.6 | 4.0 | 2.7 | 1.5 | - | - | - | - | - | - | - | - |
P/CF |
-15.4 | -6.7 | -3.6 | -5.3 | -4.9 | - | - | - | - | - | - | - | - |
ROE % |
-65.72 | -95.51 | -69.87 | -60.01 | -40.32 | - | - | - | - | - | - | - | - |
ROA % |
-25.27 | -38.44 | -28.50 | -42.87 | -35.82 | - | - | - | - | - | - | - | - |
ROCE % |
-43.90 | -92.38 | -144.26 | -46.90 | -40.96 | - | - | - | - | - | - | - | - |
Current Ratio |
1.6 | 1.7 | 1.7 | 12.8 | 9.1 | - | - | - | - | - | - | - | - |
DSO |
90.1 | 64.6 | 31.2 | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
90.0 | 64.6 | 31.1 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
90.0 | 64.6 | 31.1 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Mirum Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.3 | -0.52 | -0.54 | - | -0.57 | -1.94 | -0.8 | - | -1.02 | -0.84 | -1.17 | - | -1.55 | -1.45 | -1.68 | - | -0.86 | -0.93 | -0.86 | - | -0.84 | -5.31 | -2.37 | - | -0.14 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.14 | -0.39 | -0.44 | - | -0.55 | -0.6 | -0.69 | - | -0.91 | -0.96 | -1.04 | - | -1.4 | -1.24 | -1.58 | - | -0.86 | -0.94 | -0.89 | - | -0.88 | -5.48 | -2.46 | - | -0.14 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-36.44 | -39.07 | -122.49 | -124.30 | -145.39 | -157.71 | -87.85 | -79.02 | -162.55 | -224.99 | -246.51 | -167.12 | -179.62 | -108.59 | -76.25 | -38.39 | -49.96 | -49.04 | -45.93 | -26.54 | -26.16 | -14.20 | -3.74 | 0.44 | 0.44 | 0.06 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-13.36 | -14.86 | -27.82 | -29.35 | -39.15 | -45.32 | -41.79 | -36.12 | -56.15 | -53.22 | -70.95 | -60.49 | -69.42 | -58.32 | -50.25 | -27.43 | -37.71 | -39.07 | -38.65 | -23.58 | -23.71 | -13.56 | -4.34 | -0.15 | -0.15 | -0.02 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-36.68 | -40.56 | -60.85 | -59.46 | -78.88 | -88.96 | -86.48 | -77.88 | -153.81 | -210.33 | -220.99 | -150.56 | -163.18 | -99.87 | -74.51 | -39.13 | -51.31 | -50.86 | -47.91 | -27.68 | -27.31 | -14.76 | -3.99 | 0.38 | 0.38 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.5 | 1.5 | 1.6 | 1.6 | 1.7 | 1.2 | 1.7 | 1.7 | 1.9 | - | 1.6 | 1.7 | 1.3 | 1.6 | 2.5 | 3.5 | 3.5 | 3.5 | 3.5 | 9.0 | 9.0 | 9.0 | 9.0 | 21.2 | 21.2 | 21.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
65.1 | 67.6 | 81.0 | - | 79.5 | 73.0 | 70.2 | - | 39.7 | 20.5 | 39.4 | - | 3.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
65.1 | 67.6 | 81.0 | - | 79.5 | 73.0 | 70.2 | - | 39.7 | 20.5 | 39.4 | - | 3.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
65.1 | 67.6 | 81.0 | - | 79.5 | 73.0 | 70.2 | - | 39.7 | 20.5 | 39.4 | - | 3.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency